Business
NeuroOne Medical Technologies Corporation Receives FDA 510(k) Clearance for Evo(TM) Cortical Electrode
The Company believes that the Evo Cortical Electrode is the first cortical electrode to receive FDA 510(k) clearance that uses thin film printed microcircuit
About this update from Neuroone Medical Technologies Corporation
[{"type":"text","content":"The Company believes that the Evo Cortical Electrode is the first cortical electrode to receive FDA 510(k) clearance that uses thin film printed microcircuit technology manufactured using a fully automated photolithographic process EDEN PRAIRIE, MN / ACCESSWIRE / December 2, 2019 / NeuroOne Medical Technologies Corporation (OTCQB:NMTC), a medical device company focused on the development and commercialization of thin film electrode technology for recording brain activity, stimulation and ablation solutions for patients suffering from Epilepsy, Parkinson's Disease, and back pain, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market its thin film cortical electrode technology for temporary (less than 30 days) recording, monitoring, and stimulation on the surface of the brain.The Evo Cortical Electrode product line is the result of a collaboration with both Wisconsin Alumni Research Foundation and Mayo Foundation for Medical Education and Research. This thin film technology offers the potential for improved resolution during recording brain activity, future placement through a less invasive procedure, and reduced inflammation of brain tissue as demonstrated in testing conducted at the Mayo Clinic.\"This is certainly a monumental achievement for the Company,\" stated Dave Rosa, NeuroOne's President and CEO. \"A great deal of work, perseverance and commitment from our employees, development partners, consultants and manufacturing partners made this possible. This 510(k) clearance is a critical step in executing our corporate strategy, and we look forward to working towards our goal of applying this platform to a variety of other devices for recording, monitoring and stimulation for various therapeutic applications such as epilepsy, Parkinson's Disease, spinal cord stimulation and artificial intelligence.\"About NeuroOneNeuroOne Medical Technologies Corporation is a developmental stage company committed to providing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from Epilepsy, Parkinson's Disease, Essential Tremors and other related neurological disorders that may improve patient outcomes and reduce procedural costs.Forward Looking StatementThis press release may include forward-looking statements withi...